Compiles 195 contributions from the June 1996 meeting. Part I (clinical aspects and pathology) discusses the role of neuroprotection and neurorescue in ischemia, stroke, and neuronal injury, as well as neurochemical mechanisms, mood disorders, and the significance of cerebrospinal fluid examinations
Auflage
Sprache
Verlagsort
Verlagsgruppe
Kluwer Academic Publishers Group
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Research
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Illustrationen
LII, 1217 p.
Illustrations
Maße
Höhe: 254 mm
Breite: 178 mm
Gewicht
ISBN-13
978-0-306-45705-0 (9780306457050)
DOI
10.1007/978-1-4615-5405-9
Schweitzer Klassifikation
History. Clinical Aspects and Pathology: New Aspects of Alzheimer's and Other Neurodegenerative Diseases. Antidepressant and Anxiolytic Mechanisms of Serotonergic Autoreceptor Agonists. Antagonists and Reuptake Inhibitors. Mild Hypothermia in the Management of Stroke and Other Ischemic Brain Trauma; Basic Mechanisms and Clinical Experience, Neurochemistry and Neuroimmunology of EAE; Implications for Therapy of MS. Neuroprotection in Model Studies for Dementia and Ischemia. Pathogenic Mechanisms in Mood Disorders. Atypical Antipsychotics: The Neurochemical Relevance of Test Models. Cellular Functions: Neurotrophic Molecules in Development and Regeneration. Steroids and Nervous System. Molecular Mechanisms of Microglial Activation. Metabolic Trafficking in the Brain. The Functional Role of Chromogranins and Related Peptides. Role of Melatonin in the Brain and Eye. Transporters for Essential Nutrients in Brain Cells. Molecules/Methods: Neurotransmitter Transporters. Structures of Neuronal Proteins in Rationalized Drug Design. Progress in Cholinergic Neurotransmission. Cell Adhesion in Neural Plasticity Induced by Experience. Expression and Metabolism of Glycoconjugates. CNS Taurine-A New Outlook. 23 Additional Chapters. Index.